NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
Quantum BioPharma Podcast: MS Drug Candidate and Growth Strategy
Quantum BioPharma executive co-chairman Anthony Durkacz discussed the company's lead MS drug candidate Lucid-MS and its alcohol metabolism accelerator unbuzzd on the BioMedWire Podcast, highlighting the company's strategy in neurodegenerative and metabolic disorders.
The lead drug candidate is Lucid-MS, which was a key topic in the executive podcast.
Anthony Durkacz, executive co-chairman and co-founder of Quantum BioPharma, appeared as a guest.
Unbuzzd is a clinically validated alcohol metabolism accelerator designed to help sober people up faster.
The company focuses on developing treatments for neurodegenerative, metabolic, and alcohol-misuse disorders.
It allows company leaders to explain complex technologies, discuss development strategies, and provide context that is hard to capture in traditional press releases.
The latest news and updates are available in the company’s newsroom at https://ibn.fm/QNTM.
The appearance aimed to showcase Quantum BioPharma's unique MS drug candidate and growth strategy to investors and the public.